Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Healthy Returns
Recent news which mentions Healthy Returns
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Health care industry
Novartis AG
Healthy Returns
From
CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
November 13, 2024
Tags
Health care industry
Healthy Returns
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Viking Therapeutics Inc
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags
Social issues
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
LILLY DRN
Healthy Returns
Science
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Health care industry
Healthy Returns
LILLY DRN
From
CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
October 08, 2024
Tags
Health care industry
Healthy Returns
Hims & Hers Health Inc
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Health care industry
Astellas Pharma Inc
Healthy Returns
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Social issues
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Social issues
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Social issues
Berkshire Hathaway Inc
Abbott Laboratories
From
CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
Tags
Science
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
Tags
Healthy Returns
Health care industry
Science
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Breaking News: Politics
Health & Science
Healthy Returns
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
AstraZeneca PLC
Health & Science
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Health & Science
Altimmune Inc
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Science
Altimmune Inc
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Healthy Returns
Eli Lilly and Co
Health care industry
From
CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags
Moderna Inc
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Bristol/Myers Squibb Co
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags
Johnson & Johnson
Science
Health care industry
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Healthy Returns
Health care industry
Science
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Health care industry
Science
Alphabet Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Apple Inc
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Teva Pharmaceutical Industries Ltd
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.